Favicon
Favicon

Global Infectious Diseases

Though the Ragon Institute started by studying HIV, we quickly expanded to other global infectious diseases. Our expansion began with tuberculosis, which often affects people living with HIV, and soon moved to the influenza virus, which affects millions globally every year.

Our BL3 core allows us to work with many infectious pathogens safely, including tuberculosis. Our researchers, from engineers to virologists, study these diseases with the goal of developing better prevention, understanding, and treatment to achieve a global impact.

Current projects in this area include understanding the mechanisms of tuberculosis infections, developing a universal flu vaccine, and understanding how tuberculosis and HIV interact when co-infecting the same patient.

Labs Working in this Area

On Site Labs

Alter

Aaron Schmidt, PhD

LAB INFO

Balazs

Engineering Immunity Against Infectious Disease

Alejandro B. Balazs, PhD

LAB INFO

Barczak

Host-pathogen interactions in mycobacterial infection

Amy Barczak, MD

LAB INFO

Batista

B cells, antibodies, preclinical vaccinology

Facundo Batista, PhD

LAB INFO

Bryson

Immune control of mycobacteria

Bryan Bryson, PhD

LAB INFO

Carrington

Impact of immunogenetic variation on disease outcome

Mary Carrington, PhD

LAB INFO

Kwon

Mucosal Immunology, Microbiome, HIV, Clinical Research, Emerging Infectious Diseases

Douglas S. Kwon, MD, PhD

LAB INFO

Lichterfeld

Clinical trials, single cell assays, HIV cure

Mathias D. Lichterfeld, MD, PhD

LAB INFO

Lingwood

Programing vaccine antibody responses

Daniel Lingwood, PhD

LAB INFO

Shalek

Single-Cell Genomics, Systems Immunology

Alex K. Shalek, PhD

LAB INFO

Walker

HIV, virus-specific T cells, elite controllers

Bruce D. Walker, MD

LAB INFO

Explore More

Emerging Infectious Diseases

The Ragon is committed to the study of emerging infectious diseases, such as Ebola, Zika, SARS/MERS, which have a devastating global impact.

Global Infectious Diseases

Though the Ragon Institute started by studying HIV, we quickly expanded to other global infectious diseases.

Research

The Ragon’s research creates knowledge from our collaborative, cross-disciplinary approach, breaking down the silos of academia.